Unsurprisingly, public listing value continued its downward trend, seeing a 79.8% drop.
Still,softwarealongside biotech & pharma generated most of the value in Q3 2023.
It’s free, every week, in your inbox.
Cause for hope?
Nevertheless, it remains to be seen whether Europes unclear macroeconomic environment can sustain market recovery.
Story byIoanna Lykiardopoulou
Ioanna is a writer at TNW.
With a background in the humanities, she has a soft spot for social impact-enabling technologies.
Also tagged with
